Malaria
Malaria is a life-threatening infectious disease caused by Plasmodium parasites, which are transmitted to humans through the bites of infected female Anopheles mosquitoes. It primarily affects tropical and subtropical regions
Signs and Symptoms
Fever
Chills
Sweating
Headache
Muscle and joint pain
Fatigue
Nausea and vomiting
Diarrhea (in some cases)
Abdominal pain
Anemia (due to destruction of red blood cells)
Jaundice (yellowing of the skin and eyes)
Rapid breathing and heart rate
Complications
Severe anemia
Cerebral malaria (brain infection leading to seizures and coma)
Acute respiratory distress syndrome (ARDS)
Kidney failure
Liver failure
Shock and multi-organ failure
Hypoglycemia (low blood sugar)
Stillbirth or low birth weight in pregnant women
Transmission
Bite of an infected female Anopheles mosquito
Blood transfusion from an infected person
Sharing of contaminated needles or syringes
Congenital transmission (from mother to fetus during pregnancy or childbirth)
Causative Agent
Malaria is caused by Plasmodium parasites. The five main species that infect humans are:
Plasmodium falciparum (most severe and deadly)
Plasmodium vivax
Plasmodium ovale
Plasmodium malariae
Plasmodium knowlesi (zoonotic malaria)
Incubation Period
P. falciparum: 9–14 days
P. vivax & P. ovale: 12–18 days
P. malariae: 18–40 days
P. knowlesi: ~11–12 days
Reservoir
Humans (primary reservoir)
Some species (P. knowlesi) can also be found in monkeys
Prevention and Control
Vector Control:
Use insecticide-treated mosquito nets (ITNs)
Indoor residual spraying (IRS) with insecticides
Eliminate mosquito breeding sites (stagnant water)
Personal Protection:
Wear long-sleeved clothing and use insect repellents
Stay indoors during peak mosquito activity (dusk to dawn)
Chemoprevention:
Intermittent preventive treatment (IPT) in pregnant women and infants
Prophylactic antimalarial drugs for travelers to endemic areas
Vaccination:
RTS,S/AS01 (Mosquirix) vaccine is available for children in high-risk areas
Treatment
Uncomplicated Malaria:
Artemisinin-based combination therapies (ACTs) (e.g., Artemether-Lumefantrine)
Chloroquine (only for P. vivax and P. malariae where resistance is absent)
Severe Malaria:
Intravenous (IV) Artesunate followed by ACTs
Supportive care (fluids, blood transfusion, oxygen therapy)
Relapse Prevention:
Primaquine for P. vivax and P. ovale to eliminate dormant liver stages (hypnozoites)
Thank you sir
ReplyDelete